Market Closed -
Nyse
16:00:02 2024-06-12 EDT
|
5-day change
|
1st Jan Change
|
16.56
USD
|
-0.54%
|
|
-4.11%
|
+17.45%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
5,270
|
1,560
|
1,659
|
1,968
|
-
|
-
|
Enterprise Value (EV)
1 |
5,013
|
1,351
|
1,442
|
1,720
|
1,679
|
1,583
|
P/E ratio
|
-21.1
x
|
-14.1
x
|
-26.1
x
|
-131
x
|
203
x
|
94.6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
9.74
x
|
2.61
x
|
2.48
x
|
2.59
x
|
2.29
x
|
2.02
x
|
EV / Revenue
|
9.27
x
|
2.26
x
|
2.15
x
|
2.26
x
|
1.96
x
|
1.63
x
|
EV / EBITDA
|
202
x
|
49.7
x
|
27.5
x
|
24.4
x
|
18.7
x
|
13.2
x
|
EV / FCF
|
-62.3
x
|
-27.1
x
|
197
x
|
44.7
x
|
45.9
x
|
-
|
FCF Yield
|
-1.61%
|
-3.69%
|
0.51%
|
2.24%
|
2.18%
|
-
|
Price to Book
|
11.6
x
|
5.43
x
|
5.52
x
|
5.83
x
|
5.28
x
|
4.26
x
|
Nbr of stocks (in thousands)
|
113,183
|
115,624
|
117,640
|
118,862
|
-
|
-
|
Reference price
2 |
46.56
|
13.49
|
14.10
|
16.56
|
16.56
|
16.56
|
Announcement Date
|
3/17/22
|
2/28/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
393.7
|
540.8
|
598.1
|
669.8
|
760.1
|
858.1
|
972.8
|
EBITDA
1 |
-
|
24.86
|
27.2
|
52.35
|
70.41
|
89.78
|
119.9
|
EBIT
1 |
-
|
-33.12
|
-6.556
|
13.8
|
25.3
|
40.27
|
63.97
|
Operating Margin
|
-
|
-6.12%
|
-1.1%
|
2.06%
|
3.33%
|
4.69%
|
6.58%
|
Earnings before Tax (EBT)
1 |
-
|
-144
|
-109.9
|
-62.76
|
-7.114
|
24.07
|
32.22
|
Net income
1 |
-
|
-144.3
|
-110.4
|
-63.2
|
-11.76
|
13.23
|
23.32
|
Net margin
|
-
|
-26.68%
|
-18.46%
|
-9.44%
|
-1.55%
|
1.54%
|
2.4%
|
EPS
2 |
-1.050
|
-2.210
|
-0.9600
|
-0.5400
|
-0.1267
|
0.0817
|
0.1750
|
Free Cash Flow
1 |
-
|
-80.51
|
-49.81
|
7.32
|
38.45
|
36.55
|
-
|
FCF margin
|
-
|
-14.89%
|
-8.33%
|
1.09%
|
5.06%
|
4.26%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
13.98%
|
54.61%
|
40.71%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
276.36%
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
6/21/21
|
3/17/22
|
2/28/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
132.9
|
153.2
|
149.6
|
148.8
|
146.5
|
172
|
166.1
|
169.8
|
161.9
|
200
|
187
|
190.7
|
182
|
222.2
|
214.2
|
EBITDA
1 |
-6.399
|
0.774
|
5.936
|
11.93
|
8.568
|
17.74
|
14.18
|
11.03
|
9.408
|
22.38
|
17.24
|
18.61
|
12.42
|
26.6
|
22.36
|
EBIT
1 |
-12.95
|
-6.363
|
-1.944
|
2.487
|
-0.64
|
7.436
|
4.891
|
1.271
|
-0.962
|
10.32
|
6.616
|
7.784
|
0.6318
|
14.47
|
10.78
|
Operating Margin
|
-9.74%
|
-4.15%
|
-1.3%
|
1.67%
|
-0.44%
|
4.32%
|
2.94%
|
0.75%
|
-0.59%
|
5.16%
|
3.54%
|
4.08%
|
0.35%
|
6.51%
|
5.03%
|
Earnings before Tax (EBT)
1 |
-45.79
|
-33.59
|
-32.12
|
-23.86
|
-20.33
|
-10.55
|
-15.95
|
-17.11
|
-19.15
|
-2.571
|
0.1
|
3
|
-3.7
|
15
|
10
|
Net income
1 |
-45.9
|
-34.13
|
-32.17
|
-23.84
|
-20.25
|
-10.81
|
-15.92
|
-17.41
|
-19.05
|
-2.679
|
-4.734
|
0.734
|
-4.408
|
15
|
10
|
Net margin
|
-34.54%
|
-22.28%
|
-21.5%
|
-16.03%
|
-13.82%
|
-6.29%
|
-9.59%
|
-10.25%
|
-11.77%
|
-1.34%
|
-2.53%
|
0.38%
|
-2.42%
|
6.75%
|
4.67%
|
EPS
2 |
-0.4100
|
-0.3000
|
-0.2800
|
-0.2100
|
-0.1800
|
-0.0900
|
-0.1400
|
-0.1500
|
-0.1600
|
-0.0200
|
-0.0533
|
-0.003330
|
-0.0500
|
0.0400
|
0.0100
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/17/22
|
5/16/22
|
8/11/22
|
11/10/22
|
2/28/23
|
5/9/23
|
8/9/23
|
11/8/23
|
2/28/24
|
5/9/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
256
|
209
|
217
|
248
|
289
|
386
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-80.5
|
-49.8
|
7.32
|
38.5
|
36.6
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-328%
|
-1.29%
|
4.01%
|
7.43%
|
9.11%
|
12.9%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
4.010
|
2.490
|
2.550
|
2.840
|
3.140
|
3.880
|
Cash Flow per Share
2 |
-
|
-
|
0.0900
|
0.5200
|
-0.5100
|
-0.5500
|
-
|
Capex
1 |
-
|
48.5
|
60.2
|
54.7
|
52.8
|
56
|
64.5
|
Capex / Sales
|
-
|
8.97%
|
10.06%
|
8.16%
|
6.94%
|
6.52%
|
6.63%
|
Announcement Date
|
6/21/21
|
3/17/22
|
2/28/23
|
2/28/24
|
-
|
-
|
-
|
Last Close Price
16.56
USD Average target price
16.5
USD Spread / Average Target -0.36% Consensus |
1st Jan change
|
Capi.
|
---|
| +17.45% | 1.97B | | +13.99% | 103B | | +25.90% | 45.54B | | +0.21% | 18.88B | | -22.14% | 2.18B | | +19.55% | 1.15B | | -41.95% | 674M | | -10.65% | 650M | | +60.91% | 622M | | -46.34% | 631M |
Glasses, Spectacles & Contact Lenses
|